Skip to content
    Compare notes on r/BodyHackGuideCompare notes with other researchers. Join r/BodyHackGuide

    KW-6356

    Nootropics

    Status
    Phase 2b (program discontinued), , not approved for human use
    Evidence

    Small human trials, graded on the Adenosine Bench

    KW-6356 is a selective adenosine A2A receptor antagonist/inverse agonist developed by Kyowa Kirin and studied for Parkinson's disease, both as monotherapy and as an add-on to levodopa.

    Reviewed

    01Overview

    What KW-6356 is

    Adenosine A2A receptors are concentrated in the basal ganglia, where they oppose dopamine signaling, so blocking them is a non-dopaminergic way to support motor function. It is a structurally distinct successor to istradefylline (Nourianz).

    How it works

    KW-6356 binds adenosine A2A receptors as a high-affinity antagonist and inverse agonist, reducing both adenosine-stimulated and constitutive A2A signaling in striatal output pathways. By relieving A2A-mediated inhibition of dopaminergic motor circuits it improves motor output without directly stimulating dopamine receptors. The same A2A antagonism underlies the wakefulness and anti-fatigue effects researched for this receptor class, which caffeine hits non-selectively.

    Benefits listed

    • Selective adenosine A2A antagonism / inverse agonism
    • Studied for motor symptoms in Parkinson's disease (Phase 2a monotherapy + Phase 2b adjunct)
    • Non-dopaminergic mechanism
    • Researched for the wakefulness / anti-fatigue effects of A2A blockade

    02Research

    Free with email

    What the research shows

    Graded on a research bench

    Reference pages that put KW-6356 next to the compounds people pair it with: roles, evidence, overlap and conflicts. No dosing. Research use only.

    Unlock the Research section

    Enter your email to keep reading. It is free, and it opens these sections on every compound page in this browser.

    • Safety and side effects
    • A link to the PubMed results

    You also get the free peptide cheat sheet by email. Unsubscribe anytime.

    Have an account? Sign in

    03Safety

    KW-6356 side effects and interactions

    Side effects

    Not in our record

    Our record lists no side effects for KW-6356. That means none are recorded here, not that there are none. The Research section has the written safety notes.

    Who should not use it

    Contraindications

    Investigational compound with no clinical-use guidance. Avoid in pregnancy/breastfeeding.

    Interactions

    Not in our record

    Our record lists no interactions for KW-6356. That means none are recorded here, not that none exist.

    This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.

    Need bloodwork before starting?

    Full hormone + metabolic panels from Anabolic Insights. Code CHONCH for first-order discount.

    Order Bloodwork

    04Dosing

    Free with email

    Dosing

    No dose on record

    Our record lists no dose for KW-6356. This section holds what it does list.

    Unlock the Dosing section

    Enter your email to keep reading. It is free, and it opens these sections on every compound page in this browser.

    • Route

    You also get the free peptide cheat sheet by email. Unsubscribe anytime.

    Have an account? Sign in

    05Prices

    KW-6356 prices

    1 listing from 1 vendor, opening in the Featured order.

    Pack prices
    $109.99
    Lowest per mg
    Not listed
    Vendors
    1
    Listings
    1 (capsule)

    Prices as the vendors list them, last recorded 22 September 2026.

    Form
    Sort
    KW-6356 listings, in Featured order
    VendorProductPriceBuy

    KW-6356

    capsule, 1 bottle

    In stock

    $109.99

    No mg count

    Buy KW-6356 at BHG Labs
    Vendors selling KW-6356(1: trust score, certificates, payment, shipping)

    Every supplier above is graded 0 to 100 on COA verification, payment transparency, shipping, reviews, and active listings. Methodology published, no pay-to-rank. How we score these vendors

    Review KW-6356

    Sign in to leave a review

    Reviews on BodyHackGuide are tied to verified user accounts and moderated before publishing. Sign in (free, no spam) to share your experience with KW-6356.

    06Chemistry

    Chemistry and structure

    Molecular mass
    397.4 g/mol
    CAS number
    858979-50-7

    08Questions

    Frequently asked questions

    What is KW-6356 used for in research?

    KW-6356 is a selective adenosine A2A receptor antagonist/inverse agonist developed by Kyowa Kirin and studied for Parkinson's disease, both as monotherapy and as an add-on to levodopa. Adenosine A2A receptors are concentrated in the basal ganglia, where they oppose dopamine signaling, so blocking them is a non-dopaminergic way to support motor function. It is a structurally distinct successor to istradefylline (Nourianz).

    What forms does KW-6356 come in?

    KW-6356 is available in capsule form.

    How do I compare KW-6356 vendors?

    Compare prices, payment methods, shipping, and COA scores across 1 vendor.

    How many vendors sell KW-6356, and what does it cost per mg?

    1 of the vendors BodyHackGuide tracks list KW-6356 (1 listing). The lowest listed price BodyHackGuide has recorded for KW-6356 is $109.99. No KW-6356 listing recorded as in stock carries a milligram count, so BodyHackGuide states no price per milligram for KW-6356.

    Which vendors have third-party COAs for KW-6356 on file at BodyHackGuide?

    BodyHackGuide holds no third-party certificate records for KW-6356. Each vendor page on BodyHackGuide shows how many certificate records BodyHackGuide holds for that vendor.

    Related

    Articles on KW-6356

    Free 2026 Peptide Cheat Sheet (PDF)

    38 compounds and blends: vial sizes, BAC water volumes, dosing ranges and bloodwork markers.

    Download Free